<html>
<head>PUBMED IDs for XYLT2</head>
<body bgcolor='#C5F0F2'><h1>XYLT2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17189266/'>Biosynthesis of chondroitin and heparan sulfate in chinese hamster ovary cells depends on xylosyltransferase II.</a> December 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19690584/'>Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease.</a> February 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19944077/'>Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans.</a> March 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21159603/'>Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons.</a> March 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22117070/'>Molecular cloning of a xylosyltransferase that transfers the second xylose to O-glucosylated epidermal growth factor repeats of notch.</a> March 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22886070/'>First identification and functional analysis of the human xylosyltransferase II promoter.</a> September 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24338203/'>Effects of sesamin on the biosynthesis of chondroitin sulfate proteoglycans in human articular chondrocytes in primary culture.</a> May 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25024048/'>Blood cells transcriptomics as source of potential biomarkers of articular health improvement: effects of oral intake of a rooster combs extract rich in hyaluronic acid.</a> July 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25704086/'>Identification and characterization of human xylosyltransferase II promoter single nucleotide variants.</a> May 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25704082/'>Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.</a> May 20  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27871115/'>Abnormal Proteoglycan Synthesis Due to Gene Defects Causes Skeletal Diseases with Overlapping Phenotypes.</a> March 8  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27871071/'>WT1 Expression in Patients with Myelodysplastic Syndromes: A Variety of Possibilities in Future Clinical Practice.</a> November 22  2016<br></body></html>
